Beranda › Hipertensi Arteri Pulmonal › Kansas
Uji klinis Hipertensi Arteri Pulmonal di Kansas
7 studi untuk Hipertensi Arteri Pulmonal mencari peserta di lokasi di Kansas.
Kota di Kansas
Teks studi resmi (Bahasa Inggris)
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
- USA010, Kansas City
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07481981An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
- University of Kansas Medical Center, Kansas City
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07365332A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- The University of Kansas Medical Center Research Institute, Kansas City
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT07175038Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
- University of Kansas Medical Center, Kansas City
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT06274801A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
- U of Kansas Medical Center, Kansas City
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 21 Jul 2026 · NCT06649110Pulmonary Hypertension Association Registry
- KU Medical Center, Kansas City
Menerima pesertaStudi observasional
Usia 0 ke atas · Semua jenis kelamin · Diperbarui 14 Nov 2025 · NCT04071327Pulmonary Hypertension Biorepository and Registry
- University of Kansas Medical Center, Kansas City
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Agu 2025 · NCT04808596Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.